Clinical Trials Logo
  1. Home
  2. Metabolic Syndrome
  3. NCT04839419
  4. Details
NCT04839419 Clinical Trial

Obesity-hypoventilation in Metabolic Syndrom Patients

Metabolic Syndrome Clinical Trial

Official title:
Prevalence of Obesity-hypoventilation Syndrome in Patients With Metabolic Syndrome.

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT04839419
Other study ID # 2019-A02866-51
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date August 1, 2020
Est. completion date August 1, 2025

Study information
Verified date November 2023
Source SOS Oxygene Mediterranee
Contact Delphine Delample, PhD
Phone 0612155648
Email d.delample@sosoxygene.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The purpose of the study is to determined the prevalence of obesity-hypoventilation syndrome in patients with metabolic syndrom.

Description:

After being informed about the study and potential risks, patient agreed to participate and undergo : a functional respiratory exploration, an arterial blood gas analyze, and a polygraphy coupled with a capnography during the same night.

Recruitment information / eligibility
Status Recruiting
Enrollment 400
Est. completion date August 1, 2025
Est. primary completion date August 1, 2025
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - BMI>30 kg/m2 - no treatment with CPAP nor NIV Exclusion Criteria: - obstructive respiratory disease - non-treated cardiac dysfunction

Study Design

Related Conditions & MeSH terms

Locations
Country Name City State
France Clinique du Château de Vernhes Bondigoux

Sponsors (1)
Lead Sponsor Collaborator
SOS Oxygene Mediterranee

Country where clinical trial is conducted

France, 

Outcome
Type Measure Description Time frame Safety issue
Primary Capnia Arterial pression in CO2 and transcutaneous pression in CO2 Up to one mont after inclusion
Primary Arterial pression in CO2 PaCO2 At the inclusion
Secondary BMI body mass index At the inclusion
Secondary Arterial pression in oxygen PaO2 At the inclusion
Secondary somnolence EPWORTH questionnaire; Minimum = 0; Maximum = 24, Higher score means a worth outcome At the inclusion
Secondary Physical activity level Ricci&Gagnon questionnaire, Minimum = 9; Maximum = 45, Higher score means a worth outcome At the inclusion
Secondary Arterial blood bicarbonates HCO3- At the inclusion
Secondary Arterial blood gases pH At the inclusion
Secondary Hemoglobin Hb At the inclusion
Secondary obstructive sleep apnea items Apnea-hypopnea index Up to one mont after inclusion
Secondary Night Oxygen saturation SpO2 Up to one mont after inclusion
See also
  Status Clinical Trial Phase
Recruiting NCT04635202 - Effect of Elliptical Training on Metabolic Homeostasis in Metabolic Syndrome N/A
Completed NCT05343858 - Pilot Study to Evaluate the Effect of Two Microalgae Consumption on Metabolic Syndrome N/A
Completed NCT04053686 - An Intervention to Reduce Prolonged Sitting in Police Staff N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Recruiting NCT05040958 - Carotid Atherosclerotic Plaque Load and Neck Circumference
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Active, not recruiting NCT02500147 - Metformin for Ectopic Fat Deposition and Metabolic Markers in Polycystic Ovary Syndrome (PCOS) Phase 4
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Completed NCT03289897 - Non-invasive Rapid Assessment of NAFLD Using Magnetic Resonance Imaging With LiverMultiScan N/A
Recruiting NCT05956886 - Sleep Chatbot Intervention for Emerging Black/African American Adults N/A
Completed NCT06057896 - Effects of Combined Natural Molecules on Metabolic Syndrome in Menopausal Women
Active, not recruiting NCT03613740 - Effect of Fucoxanthin on the Metabolic Syndrome, Insulin Sensitivity and Insulin Secretion Phase 2
Completed NCT04498455 - Study of a Prebiotic Supplement to Mitigate Excessive Weight Gain Among Physicians in Residency Phase 4
Completed NCT05688917 - Green Coffee Effect on Metabolic Syndrome N/A
Completed NCT04117802 - Effects of Maple Syrup on Gut Microbiota Diversity and Metabolic Syndrome N/A
Completed NCT03697382 - Effect of Daily Steps on Fat Metabolism N/A
Completed NCT03241121 - Study of Eating Patterns With a Smartphone App and the Effects of Time Restricted Feeding in the Metabolic Syndrome N/A
Completed NCT04509206 - Virtual Teaching Kitchen N/A
Completed NCT05124847 - TREating Pediatric Obesity N/A